Remove DNA Remove Vaccine Remove Virus
article thumbnail

Accelerating recombinant protein vaccine discovery

Drug Discovery World

Vaccination responses need to be rapid, efficacious and cost-effective if they are to outpace new viral threats emerging across the globe, says Jian He (Jason) , Chemistry, Manufacturing and Controls (CMC) Head, WuXi Vaccines. This would give more people much faster access to more effective vaccines.

Vaccine 147
article thumbnail

Immunity biochemist James Chen scoops Lasker Award 

Drug Discovery World

“Dr Chen’s research has elucidated the process by which our bodies fight off invasive pathogens, including viruses, bacteria, and other microbes, through the detection of wayward intracellular nucleic acids.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How monkeypox evolves to evade drugs 

Drug Discovery World

A team of researchers have identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness. Mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and vaccines. . Monkeypox has infected more than 77,000 people in more than 100 countries worldwide.

Virus 130
article thumbnail

Recombinant polyclonal drug trial for HBV gets FDA green light

Drug Discovery World

The US Food and Drug Administration (FDA) has cleared GigaGen’s application to initiate a Phase I trial of its polyclonal drug for the treatment of hepatitis B virus (HBV) infection, GIGA-2339. In mouse models, GIGA-2339 neutralised and cleared HBV’s viral DNA along with its antigens.

article thumbnail

This week in drug discovery (18 -22 July)

Drug Discovery World

Covid-19 vaccines remain effective six months after second dose . Two doses of Covid-19 vaccines were sufficient in providing protection against severe cases of the infectious disease, according to new research.? . Junk DNA could lead to cancer, study says . News round-up by DDW’s Reece Armstrong for 18 – 22 July.

DNA 130
article thumbnail

Day Zero Antivirals for Future Pandemics

Codon

He also explains how they could be used to combat pandemics on “day zero,” well before vaccines are developed. After the outbreak ended, it took another three years for the first Ebola vaccine by Merck to be approved. Timelines for vaccine development are shrinking, but can it move even faster?

RNA 87
article thumbnail

Drug discovery and development trends – what will have most impact?

Drug Discovery World

Hosted by DDW and sponsored by DNA Script, join us for this free-to-attend roundtable to learn about the biggest opportunities for the future of drug discovery and development. How important will mRNA-based vaccines be in treating viruses and diseases such as cancer? What can we expect from the cell & gene therapy market?

DNA 130